All the meta-analyses studies revealed a significant association between high SIRT1 with poor OS in these solid carcinomas including breast cancer [28], hepatocellular carcinoma [29], colorectal cancer [30], lung cancer [31, 32], liver cancer [32]. This evidence concerns the gene SIRT1 and lung cancer.